Michael Hearne - 12 Jan 2022 Form 4 Insider Report for LA JOLLA PHARMACEUTICAL CO (LJPC)

Role
Chief Financial Officer
Signature
/s/ Michael Hearne
Issuer symbol
LJPC
Transactions as of
12 Jan 2022
Transactions value $
$0
Form type
4
Filing time
14 Jan 2022, 17:27:23 UTC
Previous filing
04 Jan 2022
Next filing
19 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LJPC Employee Stock Option (Right to Buy) Award $0 +78.6K $0.00 78.6K 12 Jan 2022 Common Stock 78.6K $4.81 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years.